Skip to main content

Advertisement

SpringerLink
Log in

Analysis of albumin fatty acid binding capacity in patients with benign and malignant colorectal diseases using electron spin resonance (ESR) spectroscopy

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Introduction

In colorectal cancer (CRC), no biological marker is known that could serve both as a marker for detection and prognosis. Electron spin resonance (ESR) spectroscopy of spin-labeled fatty acid (FA) molecules binding to human serum albumin is a suitable method for the detection of conformational changes and alterations of transport function of albumin through changes in its FA binding capabilities.

Objective

The aim of this study was to examine whether the FA binding to albumin is detectably and significantly altered in CRC patients when compared with patients having benign colorectal diseases.

Materials and methods

One hundred four patients operatively or endoscopically treated for CRC, sigmoid diverticulitis, or a colorectal adenoma were examined before procedure. Albumin was analyzed by ESR with spin-labeled FA. A determination ratio (DR) was calculated from the measured ESR spectra as ratios of the fraction of FA that is tightly bound vs. the fractions that are loosely interacting with albumin or are unbound.

Results and discussions

Patients with CRC showed significantly lower DR values (DR, −0.09 ± 0.98 vs. 0.61 ± 1.43) than patients with benign colorectal diseases, consistent with a change of conformation and transport function of albumin in CRC. Within the CRC group, with advanced tumor stage, the difference in DR values increased. ESR of FA binding to albumin thus seems to be suitable for detection of patients with CRC. Furthermore, a correlation with advanced tumor stage can be established.

Conclusions

These results suggest that a further evaluation of the role of ESR in patients with all stages of CRC should take place. It should also be examined whether ESR might play a role in detecting CRC in a larger panel of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Kahi CJ, Rex DK, Imperiale FI (2008) Screening, surveillance and primary prevention for colorectal cancer: a review of the recent literature. Gastroenterology 135:380–399

    Article  PubMed  Google Scholar 

  2. Hundt S, Haug U, Brenner H (2007) Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 16:1935–1953

    Article  CAS  PubMed  Google Scholar 

  3. Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C, Topolcan O (2007) Tumor markers in colorectal cancer: European Group on Tumor Markers (EGTM) guidelines for clinical use. Eur J Cancer 43:1348–1360

    Article  CAS  PubMed  Google Scholar 

  4. Greene FL, Balch CM, Fleming ID (2002) AJCC cancer staging handbook, 6th edn. Springer, New York

    Google Scholar 

  5. Allegra C, Sargent DJ (2005) Adjuvant therapy for colon cancer—the pace quickens. N Engl J Med 352:2746–2748

    Article  CAS  PubMed  Google Scholar 

  6. Peters T (1996) All about albumin. Biochemistry, genetics, and medical application. Academic, San Diego

    Google Scholar 

  7. Curry S, Mandelkow H, Brick P, Franks N et al (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 5:827–835

    Article  CAS  PubMed  Google Scholar 

  8. Simard JR, Zunszain PA, Hamilton JA, Curry S (2006) Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. J Mol Biol 361:336–351

    Article  CAS  PubMed  Google Scholar 

  9. Kragh-Hansen U, Chuang VT, Otagiri M (2002) Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 25:695–704

    Article  CAS  PubMed  Google Scholar 

  10. Mehta AI, Ross S, Lowenthal MS, Fusaro V, Fishman DA, Petricoin EF, Liotta LA (2003) Biomarker amplification by serum carrier protein binding. Dis Markers 19:1–10

    CAS  PubMed  Google Scholar 

  11. Liotta LA, Ferrari M, Petricoin E (2003) Clinical proteomics: written in blood. Nature 425:905

    Article  CAS  PubMed  Google Scholar 

  12. Ge MT, Rananavare SB, Freed JH (1990) ESR studies of stearic acid binding to bovine serum albumin. Biochim Biophys Acta 1036:228–236

    CAS  PubMed  Google Scholar 

  13. Livshits VA, Marsh D (2000) Fatty acid binding sites of serum albumin probed by non-linear spin-label EPR. Biochim Biophys Acta 1466:350–360

    Article  CAS  PubMed  Google Scholar 

  14. Matthes G, Seibt G, Muravsky V, Hersmann G, Dornheim G (2002) Albumin transport analysis of different collected and processed plasma products by electron spin resonance spectroscopy. Transfer Apheresis Sci 27:129–135

    Article  CAS  Google Scholar 

  15. Hinderberger D, Jeschke G (2006) Site-Specific Characterization of Structure and Dynamics of Complex Materials by EPR Spin Probes. Modern Magnetic Resonance 3:1509–1517

    CAS  Google Scholar 

  16. Muravsky VA, Matthes G, Seibt G, Milutin A (2000) Verfahren zur Diagnose und/oder Überwachung physiologischer oder pathologischer Veränderungen im menschlichen oder tierischen Körper und ESR-Spektrometer zur Durchführung des Verfahrens. Patent DE10011163 (28.02.2000) (PCT/EP01/02248), (WO 01/65270)

  17. Gurachevsky A, Muravskaya E, Gurachevskaya T, Smirnova L, Muravsky V (2007) Cancer-associated alteration in fatty acid binding to albumin by spin-lapel electron spin resonance. Cancer Invest 25:378–383

    Article  CAS  PubMed  Google Scholar 

  18. Kazmierczak SC, Gurachevsky A, Matthes G, Muravsky V (2006) Electron spin resonance spectroscopy of serum albumin: a novel test for cancer diagnosis and monitoring. Clin Chem 52:2129–2134

    Article  CAS  PubMed  Google Scholar 

  19. Hansen O, Stock W (1999) Prophylaktische Operation bei der Divertikelkrankheit des Kolons—Stufenkonzept durch exakte Stadieneinteilung. Langenbecks Arch Chir (Suppl II):1257–1260

  20. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP (2000) American Joint Committee on Cancer Prognostic Factors Consensus Conference. Cancer 88:1739–1757

    Article  CAS  PubMed  Google Scholar 

  21. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48:1296–1304

    CAS  PubMed  Google Scholar 

  22. Mashevsky A, Muravsky V, Milutin A, Javrid E, Korotkevich E, Prokchorova V et al (1994) Dynamics of ESR spectra of the spin labeled blood serum under neoplastic process. Ukr Radiol Zh 4:268–270

    Google Scholar 

  23. Afanas'eva AN, Evtushenko VA (2004) Conformation changes in albumin molecule as a marker of dissemination of the tumor process. Bull Exp Biol Med 138:177–178

    PubMed  Google Scholar 

  24. Hinderberger D, Schmelz O, Rehahn M, Jeschke G (2004) Electrostatic site attachment of divalent counterions to rodlike ruthenium(II) coordination polymers characterized by ESR spectroscopy. Angewandte Chemie 116:4716–4721

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General and Visceral Surgery, Augusta-Kranken-Anstalt, Bergstrasse 26, 44791, Bochum, Germany

    Marcos Gelos & Benno Mann

  2. Max Planck Institute for Polymer Research, Mainz, Germany

    Dariush Hinderberger

  3. Department of General and Visceral Surgery, HELIOS Klinik St. Josefs-Hospital, Bochum-Linden, Germany

    Ellen Welsing

  4. Department of Management, Technology and Economics, Swiss Federal Institute of Technology, Zürich, Switzerland

    Julia Belting

  5. Med Innovation GmbH, Wildau, Germany

    Kerstin Schnurr

Authors
  1. Marcos Gelos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dariush Hinderberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ellen Welsing
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Julia Belting
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kerstin Schnurr
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Benno Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcos Gelos.

Additional information

M. Gelos and D. Hinderberger contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gelos, M., Hinderberger, D., Welsing, E. et al. Analysis of albumin fatty acid binding capacity in patients with benign and malignant colorectal diseases using electron spin resonance (ESR) spectroscopy. Int J Colorectal Dis 25, 119–127 (2010). https://doi.org/10.1007/s00384-009-0777-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-009-0777-0

Keywords

Search

Navigation